 Home > Active Ingredient News > Antitumor Therapy > BMJ: Remote active toxicity management during chemotherapy for breast cancer patients can reduce the risk of chemotherapy adverse events

BMJ: Remote active toxicity management during chemotherapy for breast cancer patients can reduce the risk of chemotherapy adverse events

 Last Update: 2021-12-24
 Source: Internet
 Author: User

Tags

precooked turkey breast

sce event group

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Chemotherapy is an important treatment for many tumors, and chemotherapy-related toxicity is the main adverse event
.

Studies have found that emergency medical intervention during chemotherapy is very common.

Prevention Recently, researchers have investigated the effectiveness of remote active toxicity management during chemotherapy for early-stage breast cancer patients .

The study was conducted in 20 cancer centers in Ontario, Canada.

Patients were randomized to receive chemotherapy toxicity remote management or routine care.

Quality of Life

The baseline characteristics of participants in the intervention group (n=944) and the control group (n=1214) were similar, with 22% of patients older than 65 years old
.

The percentage of patients receiving intervention in each cancer center is 50-86%

The average number of emergency visits or hospitalizations in the intervention group during treatment due to chemotherapy toxicity was 0.

Differences in the risk of chemotherapy-related grade 3 adverse events between groups

Studies believe that remote active toxicity management during chemotherapy for early-stage breast cancer patients can reduce the number of emergency visits or hospitalizations caused by chemotherapy adverse events
.

In view of the uncertainty of the new coronary pneumonia epidemic, the importance of remote management of cancer patients during treatment will become more and more significant

Remote active toxicity management during chemotherapy for early-stage breast cancer patients can reduce the number of emergency visits or hospitalizations caused by adverse chemotherapy events

Original source:

Monika K Krzyzanowska et al.

Remote, proactive, telephone based management of toxicity in outpatients during adjuvant or neoadjuvant chemotherapy for early stage breast cancer: pragmatic, cluster randomised trial.
Leave a message here

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.